What is US10822354B2 about (and how does it relate to delgocitinib)?
US10822354B2 is a U.S. patent record that you can find on Google Patents by searching the exact number. To connect it specifically to delgocitinib, you typically check the patent’s title, abstract, and claims on Google Patents for mentions of delgocitinib (or its chemical name, salt forms, prodrugs, or related compounds). The key step is confirming whether delgocitinib is named in the claims or described as one of the claimed compounds/uses.
How to find US10822354B2 on Google Patents (fast)
On Google Patents, paste the number exactly:
US10822354B2
This brings up the patent page where you can view:
- bibliographic data (assignee, inventors, filing dates)
- the abstract and description
- the claims (usually the most important part for “does it cover delgocitinib?”)
- related documents, citations, and legal status
Does US10822354B2 mention delgocitinib in the claims?
If you are trying to confirm coverage, the claims section is where it matters most. Search within the Google Patents page (Ctrl+F / Cmd+F) for:
- “delgocitinib”
- “LNK-744” (if that appears as an alternative code/name)
- chemical-sounding synonyms (often listed in the specification)
- language like “a compound of Formula …” (meaning delgocitinib may be covered by a formula definition even if the brand name is not used)
Who owns US10822354B2, and who else is relevant?
Google Patents shows the assignee/owner for US10822354B2. Once you identify the assignee, you can then search that company’s portfolio for other patents referencing the same compound family, dosing regimens, or indications. This is the quickest way to see whether delgocitinib has:
- composition-of-matter coverage (covering the molecule itself)
- formulation coverage (how it’s made/delivered)
- method-of-use coverage (specific diseases, patient subsets, or treatment combinations)
What is the legal/expiration timeline likely to be?
Google Patents displays legal status events such as:
- application and patent grant dates
- maintenance/renewal status (if applicable)
- any term adjustments
- assignment history
For expiration, you’ll look at the priority/filing dates and any patent term adjustments shown on the record. Exact “when it expires” requires reading the legal status and priority information on the same Google Patents page.
Are there related patents besides US10822354B2 that matter for delgocitinib?
Delgocitinib (like many drugs) often has multiple patents in play, such as:
- earlier priority patents on the compound
- continuation filings with narrower claim sets
- separate patents on particular indications, dosing schedules, or combinations
On Google Patents, the “Cited by” and “Also published as” / family members sections can help you identify the broader patent landscape around delgocitinib.
Can you use this patent to predict generic or biosimilar entry risk?
Patent coverage risk depends on what US10822354B2 claims (compound vs. method vs. formulation) and whether those claims are enforceable (not expired, not surrendered, not invalidated). Even if US10822354B2 exists, you still need to check:
- claim scope (what exactly is covered)
- expiration date
- legal status/any challenges or litigation (Google Patents may link related documents)
If you want, I can verify the delgocitinib link precisely
If you paste the Google Patents URL for US10822354B2 (or the patent title/abstract/first independent claim text), I can tell you exactly whether delgocitinib is explicitly named, covered by formula language, or only indirectly referenced, and what the claims are likely targeting.
Sources: None provided in your message; the answer relies on how Google Patents records are structured and how to check claim coverage.